Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones

Go back to Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones
(NASDAQ: ADVM) Delayed: 4.36 --0 (-0%)
Previous Close $4.36    52 Week High $4.86 
Open $4.36    52 Week Low $2.74 
Day High $4.36    P/E N/A 
Day Low $4.36    EPS $0.00 
Volume 12,144